(Q33687994)

28 July 2017

title

Male Skeletal Health and Osteoporosis (English)

1 reference

28 July 2017

Bilezikian JP

1

1 reference

28 July 2017

Kurland ES

series ordinal

2

1 reference

28 July 2017

Rosen CJ

series ordinal

3

1 reference

28 July 2017

publication date

1 August 1999

1 reference

28 July 2017

number of pages

7

1 reference

Trends in Endocrinology and Metabolism

inferred from page(s)

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

244-250

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

28 July 2017

1 reference

7 January 2021

Gender differences in vertebral body sizes in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Heritable and life-style determinants of bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years: potential implications for the prevention of age-related bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Programming of growth hormone secretion and bone mineral density in elderly men: a hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Sex differences in geometry of the femoral neck with aging: A structural analysis of bone mineral data

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

1 reference

7 January 2021

Osteoporosis in men: epidemiology, pathophysiology, and treatment possibilities.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Pathogenesis of vertebral crush fractures in men

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Bone mass measurements: the case for selected screening?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Epidemiology and clinical features of osteoporosis in young individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Severe Osteoporosis in Men

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Genetic and environmental correlations among hormone levels and measures of body fat accumulation and topography

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Anabolic effects of parathyroid hormone on bone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2899%2900154-X

7 January 2021

10.1016/S1043-2760(99)00154-X

Identifiers

DOI

1 reference

28 July 2017

1 reference